Di Nuzzo Private Wealth, Inc. Gilead Sciences, Inc. Transaction History
Di Nuzzo Private Wealth, Inc.
- $577 Million
- Q1 2024
A detailed history of Di Nuzzo Private Wealth, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Di Nuzzo Private Wealth, Inc. holds 84 shares of GILD stock, worth $5,593. This represents 0.0% of its overall portfolio holdings.
Number of Shares
84
Previous 83
1.2%
Holding current value
$5,593
Previous $6.72 Million
99.91%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding GILD
# of Institutions
1,885Shares Held
1BCall Options Held
8.71MPut Options Held
8.02M-
Black Rock Inc. New York, NY123MShares$8.16 Billion0.21% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$7.64 Billion0.17% of portfolio
-
Capital World Investors Los Angeles, CA84.5MShares$5.63 Billion1.06% of portfolio
-
Capital Research Global Investors Los Angeles, CA61.2MShares$4.08 Billion1.05% of portfolio
-
State Street Corp Boston, MA57.7MShares$3.84 Billion0.19% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $83.5B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...